Medopad Revenue and Competitors

London, UK

Location

$184M

Total Funding

Estimated Revenue & Valuation

  • Medopad's estimated annual revenue is currently $42k per year.(i)
  • Medopad's estimated revenue per employee is $14,000
  • Medopad's total funding is $184M.

Employee Data

  • Medopad has 3 Employees.(i)
  • Medopad grew their employee count by 0% last year.

Medopad's People

NameTitleEmail/Phone
1
FounderReveal Email/Phone
2
FounderReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.5M186%N/AN/A
#2
$3.5M31N/AN/AN/A
#3
$0.6M80%N/AN/A
#4
$4.7M4224%N/AN/A
#5
$3.9M35N/AN/AN/A
#6
$0.5M7-12%N/AN/A
#7
$1.2M14N/AN/AN/A
#8
$12.9M92-19%$22.1MN/A
#9
$3.9M356%N/AN/A
#10
$18.1M129-41%N/AN/A
Add Company

What Is Medopad?

At Medopad, we want to create a world where people can live longer. A world where the best minds continue doing their best work. A world where we can spend more time with our loved ones. Our technology takes a modular approach which means we cover a wide variety of disease areas to deliver better and more personalised care by transforming the way patients and data interact with clinicians. Our Artificial Intelligence division uses data collected through our platform to generate predictive insights which will be able to detect life threatening medical conditions. We partner closely with the world's largest healthcare systems, pharma companies, research institutes, insurers and technology companies like Apple and Tencent to solve some of the biggest problems in rare, chronic and complex disease monitoring. Medopad was recently named a $1 billion health tech company in the making by KPMG.

keywords:Analytics,Enterprise Software,Finance,Health It,Healthcare,Healthcare Providers,Information Security,Marketing,Marketing Analytics,Mobile,Security

$184M

Total Funding

3

Number of Employees

$42k

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Medopad News

2022-03-22 - Huma and AstraZeneca Partner to Accelerate Innovation for ...

... .nhs.uk/covid-19-response/technology-nhs/huma-medopad-evaluation-remote-digital-care-platform/ The full report is available on request.

2022-03-22 - AstraZeneca takes stake in a start-up that helps doctors conduct clinical trials virtually

Founded in 2011 as Medopad, Huma has raised a total of more than $200 million in venture capital funding to date from investors including...

2022-03-22 - AstraZeneca deepens digital ties with Huma in pursuit of ...

Last year, Huma—originally founded in 2011 as Medopad—raised $130 million upfront from a group of investors led by Leaps by Bayer and...

2021-05-13 - UK’s healthtech startup Huma raises €107.5M to scale its digital ‘hospitals at home’ platform

The UK-based healthtech startup Medopad that rebranded to Huma back in April 2020 is on a mission to go beyond remote patient monitoring and into digital biomarkers and therapeutics. In a recent development, the healthtech company announced that it has raised $130M (approx €107.5M) in its Series ...

2021-05-13 - Huma Therapeutics pulls in $130M Series C

Digital health startup Huma Therapeutics has raised around $130 million in a round led by Leaps by Bayer and Hitachi Ventures. The company's software lets clinicians monitor patients remotely through its mobile app. The Series C includes an additional $70 million that Huma can choose to exercise ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.2M30%N/A
#2
$0.5M3-90%N/A
#3
$0.2M3N/AN/A
#4
$0.2M3N/AN/A
#5
$0.2M3N/AN/A